Daily feed · SEC Form 4 filings
Insider buying in low-priced stocks — Oct 19, 2017
Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2017 PForm 4 → | Oct 18, 5:34 pm EDT | Asterias Biotherapeutics, Inc.no symbol | BROADWOOD PARTNERS, L.P. +2Other | 1,592,308 | $2.60 | $4,140,001 | 5,292,156 | +43.0% | plan? |
| Oct 17, 2017 PForm 4 → | Oct 18, 4:15 pm EDT | Aevi Genomic Medicine, Inc.GNMX | Sol J BarerDirector | 421,032 | $1.26 | $530,500 | 1,028,032 | +69.4% | plan? |
| Oct 17, 2017 PForm 4 → | Oct 18, 4:17 pm EDT | Aevi Genomic Medicine, Inc.GNMX | Michael F ColaPresident and CEO, Director | 119,047 | $1.26 | $149,999 | 218,483 | +120% | plan? |
| Oct 16, 2017 PForm 4 → | Oct 18, 5:54 pm EDT | CROSSROADS SYSTEMS INCCRSS | Claire GogelDirector | 22,000 | $4.39 | $96,470 | 72,000 | +44.0% | plan? |
| Oct 17, 2017 PForm 4 → | Oct 18, 4:16 pm EDT | Aevi Genomic Medicine, Inc.GNMX | Garry Arthur NeilChief Scientific Officer | 75,000 | $1.26 | $94,500 | 114,774 | +189% | plan? |
| Oct 17, 2017 PForm 4 → | Oct 18, 4:16 pm EDT | Aevi Genomic Medicine, Inc.GNMX | Barbara Gayle DuncanDirector | 59,524 | $1.26 | $75,000 | 59,524 | — | plan? |
| Oct 17, 2017 PForm 4 → | Oct 18, 4:16 pm EDT | Aevi Genomic Medicine, Inc.GNMX | Wilbur H GantzDirector | 39,683 | $1.26 | $50,001 | 71,073 | +126% | plan? |
| Oct 17, 2017 PForm 4 → | Oct 18, 4:17 pm EDT | Aevi Genomic Medicine, Inc.GNMX | Alastair J ClemowDirector | 19,841 | $1.26 | $25,000 | 57,536 | +52.6% | plan? |
| Oct 17, 2017 PForm 4 → | Oct 18, 4:17 pm EDT | Aevi Genomic Medicine, Inc.GNMX | Eugene A BauerDirector | 19,841 | $1.26 | $25,000 | 165,715 | +13.6% | plan? |
| Dec 12, 2014 PForm 4 → | Oct 19, 2017, 2:57 pm EDT | LAPOLLA INDUSTRIES INCLPAD | Richard KurtzDirector, 10% Owner | 40,161 | $0.39 | $15,663 | 70,974,360 | +0.06% | plan? late |
| Oct 18, 2017 PForm 4 → | Oct 19, 9:00 am EDT | Genius Brands International, Inc.GNUS | Andy HeywardChief Executive Officer, Director, 10% Owner | 2,300 | $3.42 | $7,866 | 348,340 | +0.66% | plan? |
| Oct 10, 2017 PForm 4/A → | Oct 18, 5:37 pm EDT | Galenfeha, Inc.GLFH | James KetnerPresident/CEO, Director | 210,000 | $0.035 | $7,350 | 400,000 | +111% | plan? |
| Oct 16, 2017 PForm 4 → | Oct 18, 5:12 pm EDT | Cerecor Inc.CERC | ARMISTICE CAPITAL, LLC +2Director, 10% Owner | 4,800 | $1.08 | $5,174 | 16,004,800 | +0.03% | plan? |
| Oct 18, 2017 PForm 4 → | Oct 18, 4:09 pm EDT | General Moly, IncGMO | Bruce D HansenChief Executive Officer & CFO, Director | 10,000 | $0.32 | $3,200 | 2,955,869 | +0.34% | plan? |
| Oct 16, 2017 PForm 4 → | Oct 18, 5:11 pm EDT | AMARILLO BIOSCIENCES INCAMAR | Stephen T ChenPresident, CEO & Chairman, Director, 10% Owner | 6,000 | $0.2468 | $1,481 | 154,216 | +4.05% | plan? |
| Oct 16, 2017 PForm 4 → | Oct 18, 4:10 pm EDT | VERMILLION, INC.VRML | Valerie Barber PalmieriPresident and CEO, Director | 694 | $1.44 | $999 | 61,278 | +1.15% | plan? |
| Oct 12, 2017 PForm 4 → | Oct 18, 9:16 pm EDT | DAXOR CORPDXR | Michael Richard FeldschuhPresident & CEO, Director | 202 | $4.95 | $999 | 172,799 | +0.12% | plan? late |
| Oct 16, 2017 PForm 4 → | Oct 19, 11:24 am EDT | AMERISERV FINANCIAL INC /PA/ASRV | Robert L WiseDirector | 175 | $3.95 | $691 | 138,154 | +0.13% | plan? late |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.